Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Myeloid Malignancies × olutasidenib × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 6 Myelodysplastic Syndromes 3 Leukemia, Myelomonocytic, Chronic 2 Myeloproliferative Disorders 1 Myeloid Malignancies 1

Interventions

olutasidenib 1 fludarabine 1 Dexamethasone 1 Decitabine 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06668584 2026-03-04

A Phase II Open-label Study of Olutasidenib Post-transplant Maintenance Therapy for Patients With IDH1-mutated Myeloid Malignancies

M.D. Anderson Cancer Center

Phase 2 Recruiting

Myeloid Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡